Accelerated Aging in HIV/AIDS: Novel Biomarkers of Senescent Human CD8+ T Cells

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Chou, Jennifer P ^a   Ramirez, Christina M ^b   Wu, Jennifer E ^a   Effros, Rita B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; BIOLOGICAL MARKER; CD38 ANTIGEN; GLUCOSE TRANSPORTER 1; LEUCINE RICH REPEAT NEURONAL 3; TELOMERASE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADA GENE; ADULT; AGED; AGING; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVITY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; INTERMETHOD COMPARISON; LRRN3 GENE; LYMPHOCYTE ACTIVATION; MALE; PHENOTYPE; PREDICTION; PROTEIN EXPRESSION; SENESCENCE;

AGING; BASE SEQUENCE; BIOLOGICAL MARKERS; CD8-POSITIVE T-LYMPHOCYTES; CELL AGING; DNA PRIMERS; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84878085003     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064702     Document Type: Article

References (27)

1. Yang OO, Walker BD, (1997) CD8+ cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication. Adv Immunol 66: 273-311.
2. Bailer RT, Holloway A, Sun J, Margolick JB, Martin M, et al. (1999) IL-13 and IFN-gamma secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression. J Immunol 162: 7534-7542.
3. Appay V, Rowland-Jones SL, (2002) Premature ageing of the immune system: the cause of AIDS? Trends Immunol 23: 580-585.
4. Effros RB, Fletcher CV, Gebo K, Halter JB, Hazzard WR, et al. (2008) Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis 47: 542-553.
5. Cao W, Jamieson BD, Hultin LE, Hultin PM, Effros RB, et al. (2009) Premature aging of T cells is associated with faster HIV-1 disease progression. J Acquir Immune Defic Syndr 50: 137-147.
6. Liu Z, Cumberland WG, Hultin LE, Prince HE, Detels R, et al. (1997) Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 16: 83-92.
7. Pupilli C, Giannini S, Marchetti P, Lupi R, Antonelli A, et al. (1999) Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: effects on insulin release from human islets. Diabetes 48: 2309-2315.
8. DosReis GA, Nobrega AF, de Carvalho RP, (1986) Purinergic modulation of T-lymphocyte activation: differential susceptibility of distinct activation steps and correlation with intracellular 3′,5′-cyclic adenosine monophosphate accumulation. Cell Immunol 101: 213-231.
9. Ohta A, Madasu M, Kini R, Subramanian M, Goel N, et al. (2009) A2A adenosine receptor may allow expansion of T cells lacking effector functions in extracellular adenosine-rich microenvironments. J Immunol 183: 5487-5493.
10. Butler JJ, Mader JS, Watson CL, Zhang H, Blay J, et al. (2003) Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways. J Cell Biochem 89: 975-991.
11. Parish ST, Kim S, Sekhon RK, Wu JE, Kawakatsu Y, et al. (2010) Adenosine deaminase modulation of telomerase activity and replicative senescence in human CD8 T lymphocytes. J Immunol 184: 2847-2854.
12. Valenzuela A, Blanco J, Callebaut C, Jacotot E, Lluis C, et al. (1997) Adenosine deaminase binding to human CD26 is inhibited by HIV-1 envelope glycoprotein gp120 and viral particles. J Immunol 158: 3721-3729.
13. Valenzuela A, Blanco J, Callebaut C, Jacotot E, Lluis C, et al. (1997) HIV-1 envelope gp120 and viral particles block adenosine deaminase binding to human CD26. Adv Exp Med Biol 421: 185-192.
14. Frauwirth KA, Riley JL, Harris MH, Parry RV, Rathmell JC, et al. (2002) The CD28 signaling pathway regulates glucose metabolism. Immunity 16: 769-777.
15. Jacobs SR, Herman CE, Maciver NJ, Wofford JA, Wieman HL, et al. (2008) Glucose uptake is limiting in T cell activation and requires CD28-mediated Akt-dependent and independent pathways. J Immunol 180: 4476-4486.
16. Horvath S, Zhang Y, Langfelder P, Kahn RS, Boks MP, et al. (2012) Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol 13: R97.
17. Perillo NL, Walford RL, Newman MA, Effros RB, (1989) Human T lymphocytes possess a limited in vitro life span. Exp Gerontol 24: 177-187.
18. Saldanha SN, Andrews LG, Tollefsbol TO, (2003) Analysis of telomerase activity and detection of its catalytic subunit, hTERT. Anal Biochem 315: 1-21.
19. Azuma M, Phillips JH, Lanier LL, (1993) CD28- T lymphocytes. Antigenic and functional properties. J Immunol 150: 1147-1159.
20. Lenschow DJ, Walunas TL, Bluestone JA, (1996) CD28/B7 system of T cell costimulation. Annu Rev Immunol 14: 233-258.
21. Parish ST, Wu JE, Effros RB, (2010) Sustained CD28 expression delays multiple features of replicative senescence in human CD8 T lymphocytes. J Clin Immunol 30: 798-805.
22. Dagarag M, Evazyan T, Rao N, Effros RB, (2004) Genetic manipulation of telomerase in HIV-specific CD8+ T cells: enhanced antiviral functions accompany the increased proliferative potential and telomere length stabilization. J Immunol 173: 6303-6311.
23. Lichterfeld M, Mou D, Cung TD, Williams KL, Waring MT, et al. (2008) Telomerase activity of HIV-1-specific CD8+ T cells: constitutive up-regulation in controllers and selective increase by blockade of PD ligand 1 in progressors. Blood 112: 3679-3687.
24. Leeansyah E, Cameron PU, Solomon A, Tennakoon S, Velayudham P, et al. (2013) Inhibition of telomerase activity by HIV Nucleos(t)ide Reverse Transcriptase Inhibitors: a potential factor contributing to HIV-associated accelerated ageing. J Infect Dis.
25. Nichols WS, Schneider S, Chan RC, Farthing CF, Daar ES, (1999) Increased CD4+ T-lymphocyte senescence fraction in advanced human immunodeficiency virus type 1 infection. Scand J Immunol 49: 302-306.
26. Mandapathil M, Szczepanski M, Harasymczuk M, Ren J, Cheng D, et al. (2012) CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4(+) T effector cells in patients with head and neck squamous cell carcinoma. Oncoimmunology 1: 659-669.
27. Kaplan RC, Sinclair E, Landay AL, Lurain N, Sharrett AR, et al. (2011) T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis 203: 452-463.